1972Arthritis & RheumatismRequires access

Therapeutic studies in NZB/W mice. II. Relative efficacy of azathioprine, cyclophosphamide and methylprednisolone

Michael Gelfand, Alfred D. Steinberg

Open publisher page 84 citations

Abstract

Abstract Five‐month‐old female NZB/W mice were treated with daily injections of azathioprine, cyclophosphamide or methylprednisolone. Treatment was continued for 2 or 3 months at different dosages. Renal histology, proteinuria, antibodies to DNA and survival were studied. All drugs were found to modify the disease favorably. At low doses (1.5 mg/kg/day) azathioprine was most effective. Cyclophosphamide was superior at higher doses (4.5 mg/kg/day). Different two‐drug combinations were also compared. The combination of cyclophosphamide plus methylprednisolone was most effective. Combined therapy increased survival without increasing toxicity.

About this research paper

What this paper is about

Abstract Five‐month‐old female NZB/W mice were treated with daily injections of azathioprine, cyclophosphamide or methylprednisolone. Treatment was continued for 2 or 3 months at different dosages. Renal histology, proteinuria, antibodies to DNA and survival were studied. All drugs were found to modify the disease favorably. At low doses (1.5 mg/kg/day) azathioprine was most effective. Cyclophosphamide was superior at higher doses (4.5 mg/kg/day). Different two‐drug combinations were also compared. The combination of cyclophosphamide plus methylprednisolone was most effective. Combined therapy increased survival without increasing toxicity.

Why it matters

OpenAlex reports 84 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Abstract Five‐month‐old female NZB/W mice were treated with daily injections of azathioprine, cyclophosphamide or methylprednisolone. Treatment was continued for 2 or 3 months at different dosages. Renal histology, proteinuria, antibodies to DNA and survival were studied. All drugs were found to modify the disease favorably. At low doses (1.5 mg/kg/day) azathioprine was most effective. Cyclophosphamide was superior at higher doses (4.5 mg/kg/day). Different two‐drug combinations were also compared. The combination of cyclophosphamide plus methylprednisolone was most effective. Combined therapy increased survival without increasing toxicity.

Key concepts: Azathioprine, Cyclophosphamide, Methylprednisolone, Medicine, Dose, Proteinuria, Toxicity, Pharmacology

Related papers

Back to paper searchBrowse research topicsOriginal source
Therapeutic studies in NZB/W mice. II. Relative efficacy of azathioprine, cyclophosphamide and methylprednisolone — Research Paper | ScholarLens